Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ekmnCfbwocfbulxdIOCy

February 14, 2013
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.

  Top Story 
  • PET/MR shows promise, challenges for cardiac imaging
    Hybrid PET/MR imaging offers great potential as an effective cardiac imaging tool because of MRI's capability to yield better soft-tissue contrast without radiation exposure, according to a report published in the Journal of Nuclear Medicine. "However, there are no obvious clinical indications or killer applications yet defined for the use of the integrated PET/MR instrumentation," the authors said. The complexity of workflow is greater with MRI than CT, and MRI is not suitable for all patients, posing some challenges for incorporating PET/MR in cardiac imaging. MolecularImaging.net (2/13) LinkedInFacebookTwitterEmail this Story
 
  ADVERTISEMENT  

  Clinical News & Research 
  • Study: Selumetinib promotes radioiodine absorption in thyroid cancer
    A new kinase inhibitor called selumetinib made advanced thyroid cancer more susceptible to radioiodine, especially in patients with RAS mutations in their disease, according to a study published in the New England Journal of Medicine. The drug restored or increased the absorption of iodine in 12 of 20 patients who were previously resistant to radioiodine, according to findings on PET images. "These results provide a proof of principle that MEK inhibitors can induce iodine uptake and retention in thyroid tumors," researchers said. MedPage Today (free registration) (2/13) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  News from the Field 
  Health Policy 
  Advancing Health Care 
  • IOM: Tracking system needed to curb sales of fake drugs
    The Institute of Medicine has called for a national drug tracking system following an FDA warning on counterfeit Avastin. Such a system might utilize barcodes or electronic tags to confirm the authenticity of a medication and the ingredients used during its production, an expert said. FDA Commissioner Dr. Margaret Hamburg lauded the report. CBS News/The Associated Press (2/13) LinkedInFacebookTwitterEmail this Story
  • HHS encourages e-patients with new effort
    HHS announced plans to create a broad shift to a less hierarchical health care system and give patients and families a greater role in their own care. A new initiative aims to expand patients' access to EHRs, mobile health applications and devices, and secure electronic messaging between patients and providers, according to an article published in the journal Health Affairs. "Engaged patients ... are more likely than others to participate in preventive and healthy practices, self-manage their conditions and achieve better outcomes," said National Health IT Coordinator Dr. Farzad Mostashari. Politico (Washington, D.C.) (2/11) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
  From SNMMI 
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

  SmartQuote 
Mistakes are part of the dues that one pays for a full life."
--Sophia Loren,
Italian actress


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director:   Meryl Harold   (202) 407-7828
 
Read more at SmartBrief.com
 
 
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.®  Legal Information